InScienceWeTrust BioAdvisory’s Post

Check the summary of #Bioverse Episode 7 moderated by our own Jiamin Zhuo.

View organization page for InScienceWeTrust Community, graphic

787 followers

The #BioVerse EP007 Webinar - "Leverage Commercial Lens to Enable Effective Drug Development and Success" has concluded with a highly engaging and productive discussion. Led by a panel of experienced industry veterans, including Hui Huang, Christina J. Ansted, MPH, CCMEP, and Jiamin Zhuo. The session explored the critical, yet frequently neglected, facet of #commercial #strategy within drug development. It emphasized that commercialization transcends mere marketing at the launch phase, representing an integrated process initiated as early as the preclinical stages. Participants shared commercial insights and business development experiences, enriched with behind-the-scenes anecdotes. They specifically advised #emerging #biotech companies, including those in #China, to adopt a commercial mindset to enhance asset-building and foster partnership development.   The Importance of #Early #Commercial #Planning The discussion also illuminated common misconceptions and strategic pitfalls, such as underestimating the impact of early-stage decisions on later commercial success. For example, choice of indication, dosing strategy, and comparator selection in clinical trials can significantly influence a drug's value proposition. The discussion highlighted Selexys Pharmaceuticals' strategic shift from the crowded asthma market to the niche of sickle cell pain crisis management. This move attracted investors to its anti-P-selectin mAb, resulting in a $660 million Novartis acquisition after Phase 2 success, underscoring the importance of early commercial planning. This case highlights the indispensable role of meticulous commercial planning from the outset. #Proactive #Engagement with Key Stakeholders A significant emphasis was placed on the importance of initiating payer/KOL engagement early. This strategy is instrumental in cultivating robust relationships with key stakeholders, while also securing insights that are pivotal for shaping clinical development and market access strategies. Such proactive engagement positions companies not merely as participants in a standard procedure but as #allies committed to addressing unmet needs. This perspective can significantly set you apart from competitors, offering a distinct advantage in the marketplace.   Leveraging Commercial Insights for #Business #Development The panelists also explored the practical aspects of leveraging commercial insights for BD activities. A well-articulated commercial plan can enhance the attractiveness of an asset to potential partners and investors by demonstrating a clear understanding of the market landscape, competitive differentiation, and value drivers. This understanding, with solid evidence, can substantiate the asset's value proposition and establish trust with potential partners, leading to more favorable deal terms.   Revisit the episode by clicking here: https://lnkd.in/eB8iv7Hr

To view or add a comment, sign in

Explore topics